Clinical Trial Update: A Multicenter Observational Study of Lemborexant on Insomnia Patients With Psychiatric Disorders

View source ↗

Summary

This is an ongoing multicenter observational study evaluating lemborexant for insomnia in patients with psychiatric disorders. Recruitment is currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Psychiatric Disorders

Drugs mentioned

• Dayvigo (Lemborexant) (lemborexant)

Snippet

Sponsor: Shanghai Mental Health Center | Conditions: Insomnia, Psychiatric Disorders | Status: RECRUITING